➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
McKesson
McKinsey
Johnson and Johnson
Medtronic

Last Updated: June 22, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for ENMD-1198


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug ENMD-1198?

ENMD-1198 is an investigational drug.

There have been 8 clinical trials for ENMD-1198. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2013.

The most common disease conditions in clinical trials are Carcinoma, Neoplasms, and Ovarian Neoplasms. The leading clinical trial sponsors are CASI Pharmaceuticals, Inc., University Health Network, Toronto, and University of Colorado, Denver.

There are twelve US patents protecting this investigational drug and one hundred and twenty-five international patents.

Recent Clinical Trials for ENMD-1198
TitleSponsorPhase
A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar CarcinomaCASI Pharmaceuticals, Inc.Phase 2
A Study of ENMD-2076 in Ovarian Clear Cell CancersUniversity Health Network, TorontoPhase 2
Study of ENMD-2076 in Patients With Advanced/Metastatic Soft Tissue SarcomaUniversity Health Network, TorontoPhase 2

See all ENMD-1198 clinical trials

Clinical Trial Summary for ENMD-1198

Top disease conditions for ENMD-1198
Top clinical trial sponsors for ENMD-1198

See all ENMD-1198 clinical trials

US Patents for ENMD-1198

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
ENMD-1198   Try Before You Buy Microtubule polymerization modulators for treating LMNA-related dilated cardiomyopathy Northwestern University (Evanston, IL) Creighton University (Omaha, NE)   Try Before You Buy
ENMD-1198   Try Before You Buy Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor Novartis AG (Basel, CH) The Trustees of the University of Pennsylvania (Philadelphia, PA) University of Pittsburgh--of The Commonwealth System of Higher Education (Pittsburgh, PA)   Try Before You Buy
ENMD-1198   Try Before You Buy Producer cells for replication competent retroviral vectors Tocagen Inc. (San Diego, CA)   Try Before You Buy
ENMD-1198   Try Before You Buy Recombinant vectors Tocagen Inc. (San Diego, CA)   Try Before You Buy
ENMD-1198   Try Before You Buy Antiangiogenic agents EntreMed, Inc. (Rockville, MD)   Try Before You Buy
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for ENMD-1198

Drugname Country Document Number Estimated Expiration Related US Patent
ENMD-1198 Australia AU2014218976 2033-02-20   Try Before You Buy
ENMD-1198 Australia AU2019201075 2033-02-20   Try Before You Buy
ENMD-1198 Canada CA2901960 2033-02-20   Try Before You Buy
ENMD-1198 China CN105358576 2033-02-20   Try Before You Buy
ENMD-1198 China CN111139256 2033-02-20   Try Before You Buy
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Moodys
Mallinckrodt
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.